Dr. Shiv Rao was a cardiologist who spent half his workday typing notes instead of treating patients. So he built an AI that listens to doctor-patient conversations and writes the notes automatically. Abridge saves doctors 2+ hours per day — hours they can spend actually seeing patients or going home to their families. NVIDIA invested. CVS invested. Andreessen Horowitz invested. At $850M+ valuation, Abridge is proving that AI in healthcare works best when it handles the paperwork doctors hate, not the decisions doctors make. While Olive AI tried to automate hospital administration and failed, Abridge is succeeding by automating something doctors desperately want automated. The lesson: AI works when it solves a pain point the user actually feels.
Founded
2018
HQ
Pittsburgh, Pennsylvania
Total Raised
$212.5 million
Founder
Shiv Rao
Status
Private (valued at $850M+ as of 2024)
Website
www.abridge.comTHE ORIGIN STORY
Dr. Shiv Rao, a cardiologist, was spending 2-3 hours per night writing clinical notes after seeing patients all day.
This is a universal problem — 70% of physician burnout is attributed to documentation burden. Rao founded Abridge in Pittsburgh in 2018 to use AI to listen to clinical conversations and generate notes automatically.
The key innovation: the AI is trained on millions of real medical conversations, making it far more accurate for healthcare than general-purpose AI tools.
WHAT THEY ACTUALLY DO
Abridge uses AI to automatically transcribe, summarize, and structure doctor-patient conversations. A doctor talks to a patient normally, Abridge records the conversation, and within seconds generates a structured clinical note — saving doctors 2+ hours of documentation per day.
Revenue comes from enterprise SaaS contracts with health systems. The technology is trained specifically on medical conversations (not general-purpose AI).
THE PRODUCTS
Abridge Clinical Documentation (AI-powered medical note generation), Abridge for Patients (patient-facing conversation summaries)
HOW THEY GREW
Become the default AI scribe for every doctor in America. Abridge has partnerships with major health systems including UPMC, UCI Health, and The Permanente Medical Group (Kaiser).
The company is expanding from ambulatory (outpatient) to inpatient settings. The strategy: land one department, prove the time savings, then expand across the entire health system.
THE HARD PART
Accuracy in high-stakes settings. A medical note error can lead to wrong diagnoses, medication errors, or insurance claim denials.
Abridge must be extremely accurate — 99%+ — in a domain with complex medical terminology, accents, and context. The company also faces competition from Nuance (Microsoft) and Amazon, both of which have launched clinical documentation AI.
MONEY TRAIL
Series A
2021 · Led by
$13M raised
Series B
2023 · Led by
$30M raised
Series C
2024 · Led by
$150M raised
WHO BACKED THEM
Lightspeed Venture Partners, CVS Health Ventures, NVIDIA, Andreessen Horowitz (a16z Bio)
Related Profiles
Head-to-Head
Compare Abridge vs another company.